Skip to main content

carboprost

Generic: CARBOPROST TROMETHAMINE·Brand: CARBOPROST TROMETHAMINE, HEMABATE, Hemabate

carboprost: sourced relationships with 2 companies · 2 FDA decisions.

carboprost evidence translation

What we can confirm

2 FDA records

What it means

More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

What is verified about carboprost, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (3)
CompanyDated record stage
ANI PHARMACEUTICALS INC (ANIP)
Reported 2024-01-25 · Current development: unknownSource
Approved
DR REDDYS LABORATORIES LTD (RDY)
Reported 2019-07-02 · Current development: unknownSource
Approved
DR REDDYS LABORATORIES LTD (RDY)
Reported 2019-07-02 · Current development: unknownSource
Approved
FDA Decisions2 records
ANDA215901UNKNOWNStandardOtherInjectable
Approval(RDY)FDA ↗
ANDA211941UNKNOWNStandardOtherInjectable

Frequently asked questions

Which companies have sourced relationships with carboprost?

carboprost has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC, DR REDDYS LABORATORIES LTD.

What is carboprost's latest FDA decision?

The most recent tracked FDA decision for carboprost is Approval, dated January 25, 2024.